About Us
Science
- Overview
- Pipeline
News & Events
Menu Menu

RSC-BMCS / SCI 23rd Medicinal Chemistry Symposium

18 September 2025

RSC-BMCS/SCI 23rd Medicinal Chemistry Symposium
Cambridge, UK
14-17 September 2025

https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg 0 0 dSpeidel https://breakpointtx.com/wp-content/uploads/2022/12/BreakpointTx_Logo_RGB.svg dSpeidel2025-09-18 14:10:482025-09-04 14:11:03RSC-BMCS / SCI 23rd Medicinal Chemistry Symposium

MODULATING DNA DAMAGE RESPONSES TO CURE CANCER

Contact Us

Breakpoint Therapeutics GmbH
Essener Bogen 7
22419 Hamburg (Germany)

Telefon: +49 40 56081 180
E-mail: info@breakpointtx.com

Impressum

Registergericht: Hamburg
Registernummer: HRB 155717
Umsatzsteuer-Identifikationsnummer: DE 324 797 830

Geschäftsführer / Managing Directors
Dr. Daniel Speidel and Jonathan Hollick

Links

Privacy Statement

Breakpoint Therapeutics GmbH @ Website by FisherPaul

Privacy Statement

Fusion conference: Targeting the DNA Damage Response for Cancer ESMO Congress